Previous Close | 0.7865 |
Open | 0.8116 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.8116 - 0.8116 |
52 Week Range | 0.5690 - 1.8100 |
Volume | |
Avg. Volume | 920 |
Market Cap | 42.722M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0100 |
Earnings Date | May 26, 2024 - May 30, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
MustGrow Biologics ( CVE:MGRO ) Full Year 2023 Results Key Financial Results Revenue: CA$4.71m (up by CA$4.71m from FY...
MustGrow Biologics to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024Saskatoon, Saskatchewan--(Newsfile Corp. - April 17, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce it will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 9:30 AM (Local Time - PST). Colin Bletsky, MustGrow's ...
MustGrow has received The State of Oregon Agriculture approval to commence sales of TerraSanteTM, an organic biofertility product, in Oregon State.MustGrow's recently-awarded organic compliance certification from the USDA National Organic Program (OMRI Listed®) will apply to this Registration.Mustard-derived TerraSanteTM focuses on soil microbiome health, nutrient/water use efficiencies, and plant yields.Saskatoon, Saskatchewan--(Newsfile Corp. - February 6, 2024) - MustGrow Biologics Corp. (TSX